Cell Counting Market Size Incredible Possibilities and Growth Analysis
The cell counting market is expected to reach USD 12.32 billion by 2023 from an estimated USD 8.84 billion in 2018, at a CAGR of 6.8%.
(EMAILWIRE.COM, August 18, 2019 ) The major factors driving the growth of Cell Counting market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.
By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018
On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728
By application, the research applications segment is estimated to hold the largest share in 2018
Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market.
By end user, the research institutes segment is estimated to hold the largest share of the cell counting market in 2018
On the basis of end user, the cell counting market is segmented into research institutes, hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and other end users (food and beverage companies and environmental testing companies).
Read More@
https://www.marketsandmarkets.com/PressReleases/cell-counting.asp
North America to dominate the market in 2018
North America is expected to account for the largest share of the cell counting market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell counting market.
The prominent players in the global cell counting market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland).
Media Contact
- Mr. Shelly Singh
- raviraj.tak@marketsandmarkets.com